Csop Samsung Electronics Daily (2x) Leveraged Product(07747.HK) Closed Down 12.24% at 136.550 HKD
Newtimespace News, as of the close on May 15, Csop Samsung Electronics Daily (2x) Leveraged Product(07747.HK) closed at 136.550 HKD, down 12.24%. The ETF opened at 151.000 HKD, with a high of 152.250 HKD and a low of 125.800 HKD. The latest trading volume was 19.8723 million units, with a total turnover of 2.747 billion HKD. The asset size is approximately 17.682 billion HKD.
Csop Samsung Electronics Daily (2x) Leveraged Product(07747.HK) tracks the share price performance of Samsung Electronics ordinary shares and is managed by CSOP Asset Management Limited. This ETF is a leveraged product employing a 2x leverage strategy, aiming to achieve twice the daily return of Samsung Electronics' share price movement. The underlying asset is the global semiconductor leader Samsung Electronics, focusing on core sectors such as memory chips, smartphones, and consumer electronics. It provides investors with a tool to amplify returns and is suitable for aggressive investors with a clear view on the short-term trend of Samsung Electronics.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- PINESTONE (00804.HK): Net Proceeds of HKD 24.2 Million from Placing for Virtual Asset Licence Application and AI Application Expansion
- MICROTECH MED-B (02235.HK): Enters Raw Material Purchase Framework Agreement with Connected Person Hangzhou Shukang
- DETAI NEWENERGY (00559.HK): Enters Memorandum of Understanding for Proposed Acquisition of HKD 505 Million; Trading Remains Suspended
- SCIENTECH (02291.HK): Acquires 54.2384% Equity of Shanghai Minwei Biotechnology for RMB 1.088 Billion, Constituting Major and Connected Transaction
- CHINAHONGQIAO (01378.HK): Revises Annual Caps under Industrial Products Purchase Agreement, 2027 Cap Raised to RMB 26.24 Million